Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Human+ vs Immortals

Human+
Graded #333

Lower grade

vs+2
Immortals
Graded #286

Higher grade

The verdict

Immortals takes it — 61.8/100 to 59.8/100, but only just.

Immortals grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Immortals is a LegitScript-certified longevity telehealth platform founded by Bryan Johnson, offering compounded semaglutide (Semaglutide/Glycine/B12) and tirzepatide (Tirzepatide/Glycine/B12) as microdose… Human+ is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueImmortals +9
45
54
Dose & formulationImmortals +24
40
64
Clinical oversightImmortals +5
83
88
Labs & monitoringHuman+ +12
66
54
FulfillmentHuman+ +22
90
68
Contract termsHuman+ +21
41
20
Human+ · left barImmortals · right bar

The numbers

MetricHuman+Immortals
WeighScore59.8/10061.8/100
GradeCC
Scorecard rank#333#286
SemaglutideNot disclosed$167/mo (microdose tier, compounded)
TirzepatideNot disclosed$180/mo (microdose tier, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Human+

Graded #333 · C

Strengths

  • Cost-transparent model: a flat monthly membership with prescriptions billed at pharmacy-wholesale cost instead of marked up
  • Available via telehealth in all 50 states
  • Filled by US 503A compounding pharmacies and reviewed by board-certified US-licensed clinicians
  • Fast, fully online 5-minute intake with provider review often within hours; discreet plain packaging
  • Covers weight loss plus hair, sexual wellness, mental health, and labs under one membership

Where it loses points

  • Specific GLP-1 medications and pricing are not published — you only see them after starting the intake
  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • LegitScript certification is shown only as a self-hosted badge; no verifiable LegitScript seal was found
  • Minimal public-facing site and a flat membership fee on top of the medication cost
Immortals

Graded #286 · C

Strengths

  • LegitScript certified (ID 50458743) with board-certified U.S. physician review within 72 hours
  • Physician consult + prescription bundled in price — 'You pay for treatment. That's it' with no added fees
  • Competitive pricing: semaglutide microdose from $167/month, tirzepatide from $180/month (promotional)
  • Unlimited provider messaging for 12 months included; video consults available
  • Founded by Bryan Johnson and Kate Tolo; clinical lead Dr. Carl Seger, M.D. (preventive/longevity medicine)

Where it loses points

  • Microdose framing uses sub-clinical doses — lower weight-loss efficacy than standard GLP-1 protocols
  • Quarterly commitment only — 3-month minimum, paid upfront ($501–$540/quarter); no monthly flexibility
  • State availability not publicly listed; 'eligible U.S. states' with no specific state list
  • Labs not included; baseline bloodwork protocol not disclosed on any public page
  • Compounding pharmacy not named; no 503A/503B accreditation details disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard